<DOC>
	<DOC>NCT00238784</DOC>
	<brief_summary>The purpose of this study is to compare Symbicort Single Inhaler treatment with the Best Conventional Practice in patients with persistent asthma</brief_summary>
	<brief_title>SOLO-SymbicortÂ® in the Treatment of Persistent Asthma in Adolescents &amp; Adults</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Diagnosis of asthma &lt; 3 months Prescribed daily use of glucocorticosteroids for at least 3 months prior to Visit 1 Smoking history &gt; 10 packyears Asthma exacerbation requiring change in asthma treatment during the last 14 days prior to inclusion Any significant disease or disorder that my jeopardize the safety of the patient. Additional inclusion and exclusion criteria will be evaluated by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>